Coherus BioSciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Coherus BioSciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2023.
  • Coherus BioSciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $7.23M, a 28.2% decline year-over-year.
  • Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $43.1M, a 15% decline from 2022.
  • Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $50.7M, a 1.22% decline from 2021.
  • Coherus BioSciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $51.4M, a 34.6% increase from 2020.
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $43.1M -$7.63M -15% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 $50.7M -$627K -1.22% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 $51.4M +$13.2M +34.6% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-15
2020 $38.2M +$4.57M +13.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-06
2019 $33.6M -$1.21M -3.47% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-23
2018 $34.8M +$1.4M +4.19% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 $33.4M +$5.98M +21.8% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-27
2016 $27.4M +$10.7M +64% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-28
2015 $16.7M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.